Anogenital and oropharyngeal cancers that are attributed to oncogenic strains of the human papillomavirus (HPV) number approximately 31 500 per year in the United States (https://www.cdc.gov/cancer/hpv/statistics/cases.htm), and despite the availability of a safe and effective HPV vaccine that protects against these strains, the United States has a disappointing record of vaccine uptake after more than a decade of promoting the vaccine for adolescents.
Daley E, Thompson E, Zimet G. Human Papillomavirus Vaccination and School Entry Requirements: Politically Challenging, but Not Impossible. JAMA Pediatr. 2019;173(1):6–7. doi:10.1001/jamapediatrics.2018.3327
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: